Login to Your Account

Trevena sinks on commercial worries despite phase III APOLLO success

By Marie Powers
News Editor

Tuesday, February 21, 2017

Trevena Inc. reported top-line results from its pivotal phase III APOLLO-1 and -2 efficacy studies of lead candidate oliceridine in moderate to severe acute pain following bunionectomy and abdominoplasty, respectively.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription